Lack of carcinogenicity of lyophilized Agaricus blazei Murill in a F344 rat two year bioassay

Food and Chemical Toxicology

Volumn 46, Issue 1, 2008, Pages 87-95

  Lee, I P ^a   Kang, B H ^b   Roh, J K ^b   Kim, J R ^c  

^a Korea Food and Drug Administration   (South Korea)

^b Korea Institute of Toxicology   (South Korea)

^c Korea National Statistical Office   (South Korea)

Author keywords

ABMK; Agaricus blazei Murill; Dietary supplement; Mushroom

Indexed keywords

AGARICUS BLAZEI EXTRACT;

AGARICUS BLAZEI; ARTICLE; AUTOPSY; BIOASSAY; BODY WEIGHT; CARCINOGENICITY; CHRONIC TOXICITY; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; FOOD INTAKE; HISTOPATHOLOGY; MALE; MORTALITY; MUSHROOM; NONHUMAN; RAT; WEIGHT GAIN;

AGARICALES; AGARICUS; ANIMALS; BLOOD CELL COUNT; BODY WEIGHT; CARCINOGENICITY TESTS; CARCINOGENS; DIET; EATING; EYE DISEASES; FEMALE; FREEZE DRYING; MALE; NEOPLASMS; NO-OBSERVED-ADVERSE-EFFECT LEVEL; ORGAN SIZE; RATS; RATS, INBRED F344; SEX CHARACTERISTICS;

AGARICUS BLAZEI; BASIDIOMYCOTA; RATTUS;

EID: 37049007679     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2007.07.001     Document Type: Article

References (45)

1. Ahn W.-S., Kim D.J., Chae G.-T., Lee J.-M., Bae S.-S., Sin J.-I., Kim Y.-W., Namkoong S.-E., and Lee I.P. Natural killer cell activity and quality of life were improved by consumption of a mushroom extract, Agaricus blazei Murill Kyowa, in gynecological cancer patients undergoing chemotherapy. International Journal of Gynecological Cancer 14 (2004) 589-594
2. Armitage P. Statistical Methods in Medical Research (1971), John Wiley & Sons Inc., New York pp. 362-365
3. Bailer A.J., and Portier C.J. Effects of treatment-induced mortality and tumor-induced mortality on tests for carcinogenicity in small samples. Biometrics 44 (1988) 417-431
4. Barbisan L.F. Chemoprevention of preneoplastic liver foci development by dietary mushroom Agaricus blazei Murrill in the rat. Food and Chemical Toxicology 41 (2003) 1543-1550
5. In: Boorman G.A., Eustis S.L., Elwell M.R., Montgomery Jr. C.A., and Mackenzie W.F. (Eds). Pathology of the Fischer Rat. References and Atlas (1990), Academic Press, San Diego, CA
6. Boorman G.A., Montgomery C.A., and MacKenzie W.F. Pathology of Fischer Rat: Reference and Atlas (1993), Academic Press, Inc. pp. 557-564
7. Cox D.R. Regression models and lie tables. Journal Royal Statistical Society B34 (1972) 187-220
8. Delmanto R.D., Alves de Lima P.L., Sugui M.M., Ferreira da Eira A., Salvadori D.M.F., Speit G., and Ribeiro L.Q. Antimutagenic effect of Agaricus blazei Murill mushroom on the genotoxicity induced by cyclophosphamide. Mutation Research 496 (2001) 15-21
9. Derelanko M.J., and Hollinger M.A. CRC Handbook of Toxicology (1995), CRC Press
10. Ebina T., and Fujimia Y. Antitumor effects of a peptide-glucan preparation extracted from Agaricus blazei in a double-grafted tumor system in mice. Biotherapy 11 (1998) 259-265
11. Fisher R.A. Statistical Methods for Research Workers. 13th ed. (1958), Hafner, New York
12. Fujimia Y., Suzuki Y., Oshiman K.I., Kobori H., Moriguchi Y., Nakashima H., Matsumoto Y., Takahara S., Ebina T., and Katakura R. Selective tumoricidal effects of soluble proteoglycan extracted from Agaricus blazei Murill, mediated via natural killer cell activation and apoptosis. Cancer Immunology and Immunotherapy 46 (1998) 147-159
13. Gart J.J., Chu K.C., and Tarone R.E. Statistical issues in interpretation of chronic bioassay tests for carcinogenicity. Journal of National Cancer Institute 62 (1979) 957-974
14. Guterrez Z.R., Mantovani M.S., Eira a.F., Ribeiro L.R., and Jordao B.Q. Variation of the antimutagenicity effects of water extracts of Agaricus blazei Murill in vitro. Toxicology 18 (2004) 301-309
15. Izawa S., and Inoue Y. A screening system for antioxidants using thioredoxin-deficient yeast: discovery of thermostable antioxidant activity from Agaricus blazei Murill. Applied Microbial and Cell Physiology 64 (2004) 537-542
16. Ikekawa, T., 1989. Twenty years' studies on antitumor activities of mushrooms. Agricultural Technology Institute of Nagano Prefecture; Research Report. pp. 9-21.
17. Kaneno R., Fontanari L.M., Santos S.A., Di Stasi L.C., Filho E.R., and Eira A.F. Effects of extracts from Brazilian sun-mushroom (Agaricus blazei) on the NK activity and lymphoproliferative responsiveness of Ehrlich tumor-bearing mice. Food and Chemical Toxicology 42 (2004) 909-916
18. Kang B.H., Sohn H.Y., Ha C.S., Song S.H., Kim H.J., Song C.W., Hahn S.S., and Roh J.K. Incidence of spontaneous tumors in Ktc: Fischer 344 rats. Korean Journal of Toxicology (1994) 181-191
19. Kaplan E.L., and Meir P. Nonparametric estimation from incomplete observations. Journal of American Statistics Association 53 (1958) 457-481
20. Kuroiwa Y., Nishikawa A., Imazawa T., Kani K., Kitamura Y., Umemura T., and Hirose M. Lack of subchronic toxicity of an aqueous extract of Agaricus blazei Murrill in F344 rats. Food and Chemical Toxicology 43 (2005) 1047-1053
21. Lee IP, Ohta, T, Bae SM, Pereira MA, Steele VE., 2004. 1SY16 isolated from Agaricus blazei Murill K as a potent multipotential chemopreventive agent. In: AACR, NCI-JACR Joint Symposia, January 25-29.
22. Lee, I.P., Kirby, P.E., 2003. Mutagenic, chromosomal aberration, and genotoxic tests: a false Ames's positive results (unpublished data: SITEK GLP Study Nos. 0771-2140 and 0800-2140).
23. Luiz R.C., Jordao B.Q., Eira A.F., Ribeiro L.R., and Mantovani M.S. Mechanism of anticlastogenicity of Agaricus blazei Murill mushroom organic extracts in wild type CHO (k1) and repair deficient (xrs5) cells by chromosome aberration and sister chromatid exchange assay. Mutation Research 528 (2003) 75-79
24. Lull C., Wichers H.J., and Savekoul H.E.J. Antiinflammatory and immunomodulating properties of fungal metabolites. Mediators of Inflammation 2 (2005) 63-80
25. Matsumoto K., Ito M., Yagyu S., Ogino H., and Hirono I. Carcinogencicity examination of Agaricus bisporus, edible mushroom in rats. Cancer Letter 1-2 (1991) 87-90
26. Menoli R.C.R.N., Mantovani M.S., Ribeiro L.R., Speit G., and Jordao B.Q. Antimutagenic effects of the mushroom Agaricus blazei Murill extracts on V79 cells. Mutation Research 496 (2001) 5-13
27. Mizuno M., Morimoto M., Minato K.I., and Tsuchida H. Polysaccharides from Agaricus blazei stimulate lymphocyte T-cell subsets in mice. Bioscience Biotechnology and Biochemistry 62 (1998) 434-437
28. Mizuno M., Minato K.I., Ito H., Kawade M., Terai H., and Tsuchida H. Anti-tumor polysaccharide from the mycelium of liquid cultured Agaricus blazei Murill. Biochemistry and Molecular Biology International 47 (1999) 707-714
29. Mohr U., Dungworth M.D., and Capen C.C. Pathology of the Aging Rat vols. I-II (1992), ILSI Press, Washington, D.C
30. Nakane K., Matsuura Y., Kubo S., Takeda T., Itoh T., Okukawa K., Yano Y., and Ueda Y. Augmentation of human NK activity and maturation of monocyte-derived dendritic cells in vitro elicited by Agaricus blazei Murill. Biotherapy 15 (2001) 503-507
31. Osaki Y., Kato T., Yamamoto K., Omubo K., and Miyazaki J. Antimutagenic and bactericidal substances in the fruit body of a Basidomycetes, Agaricus blazei Murill. Yakugaku Zasshi 114 (1994) 342-350
32. Papaparaskeva C., Ioannides C., and Walker R. Agaritine does not mediate the mutagenicity of the edible mushroom Agaricus bisporus. Mutagenesis 6 3 (1991) 213-217
33. Peto R., and Peto J. Asymptotically efficient rank invariant test procedures (with discussion). Journal of Royal Statistics Society Series A 135 (1972) 185-198
34. Pinheiro F., Faria R.R., de Carmargo J.L.V., Spinardi -Barbisan A.L.T., da Eira A.F., and Barbisan L.F. Chemoprevention of preneoplastic liver foci development by dietary mushroom Agaricus blazei Murill in the rat. Food and Chemical Toxicology 41 (2003) 1543-1550
35. Pool-Zobel B.L., Schmezer P., Sinrachantanant Y., Kliagasioglu F., Reinhart K., Martin R., Klein P., and Tricker A.R. Mutagenic and genotoxic activities of extracts derived from the cooked and raw edible mushroom Agaricus bisporus. Journal of Cancer Research Clinical Oncology 116 (1990) 475-479
36. Portier C.J., and Bailer A.J. Testing for Increased carcinogenicity using a survival adjusted quantal response test. Fundamental Applied Toxicology 12 (1989) 731-737
37. Tarone R.E. Tests for trend in life table analysis. Biometrika 62 (1975) 679-682
38. Tashima K. Biological Reference Data Book on Experimental animals (1989), Soft Science, Inc., Tokyo, Japan pp. 485-515
39. Toth B., and Erickson J. Cancer induction in mice by feeding of the uncooked cultivated mushroom of commerce Agaricus bisporus. Cancer Research 46 (1986) 4007-4011
40. Toth B., Erickson J., and Gannett P. Lack of carcinogenicity by the baked mushroom Agariscus bisporus in mice: Different feeding regimen. In Vitro 11 (1997) 227-232
41. Toth B., Erickson J., Gannett P., and Patil K. Carcinogenesis by the cultivated baked Agaricus bisporus mushroom in mice. Oncology Reports 4 (1997) 931-936
42. Toth B., Raha C.R., Wallcave L., and Nagel D. Attempted tumor induction with agaritine in mice. Anticancer Research 1 (1981) 255-258
43. Toth B., and Sorenson H. Lack of carcinogenicity of agaritine by subscutaneous administration in mice. Mycopathologia 85 (1984) 75-79
44. Walton K., Coombs M.M., King L.J., Walker R., and Ioannides C. Fate of the mushroom hydrazine agaritine in the rat and mouse. Nutrition Research 37 1 (2000) 55-64
45. Zheng, M.S., 2005. In vitro bacterial reverse mutation study of ABMK-22 (unpublished data: In vitro bacterial reverse mutation study of ABMK-22, Biotox. Tech., Co. Ltd. GLP study report No. B04027).